| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |